Aptevo gets $50/share takeout offer from shareholder Tang
Nov. 18, 2020 6:12 PM ETAptevo Therapeutics Inc. (APVO)APVOBy: Carl Surran, SA News Editor4 Comments
- Aptevo Therapeutics (NASDAQ:APVO) +35.7% after-hours following a disclosure that 42.5% shareholder Tang Capital Partners offered to buy the remaining shares for $50/share in cash.
- Shares have surged nearly 6x this month since announcing a complete remission in a Phase 1 clinical trial evaluating lead candidate APVO436 in patients with acute myeloid leukemia and myelodysplastic syndromes.
- Aptevo might be very close to being cash flow positive over the next 12 months, George Kesarios writes in a bullish analysis published recently on Seeking Alpha.